(Q33371184)

26 July 2017

title

The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients (English)

1 reference

26 July 2017

The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients (English)

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

1 reference

antiphospholipid syndrome

1 reference

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

author

Ricard Cervera i Segura

3

object named as

Cervera R

1 reference

26 July 2017

1

Font J

1 reference

26 July 2017

8

Ingelmo M

1 reference

26 July 2017

López-Soto A

2

1 reference

26 July 2017

Pallarés L

5

1 reference

26 July 2017

A. López-Soto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669849

25 October 2022

R. Cervera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669849

25 October 2022

J. Balasch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669849

25 October 2022

L. Pallarés

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669849

25 October 2022

M. Navarro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669849

25 October 2022

X. Bosch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669849

25 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1669849

25 October 2022

publication date

1 January 1991

1 reference

full work available at URL

26 July 2017

http://www.tandfonline.com/doi/pdf/10.3109/08916939108997126

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

69-75

1 reference

Thrombosis in patients with the lupus anticoagulant

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Anticardiolipin antibodies--clinical associations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Antiphospholipid antibodies: more than just a disease marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Antiphospholipid antibodies: which and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Migraine and the lupus anticoagulant. Case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108997126

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

21 January 2018

4

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients

25 October 2022

15

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

16

15

1742

Asherson R A

1988

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

19

16

482

Alarcon-Segovia D

1989

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

25 October 2022

32

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

Antiphospholipid antibodies

25 October 2022

34

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

Antiphospholipid antibodies in early repeated abortions: a case-controlled study

25 October 2022

35

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

Antiphospholipid antibodies in unselected patients with repeated abortion

25 October 2022

36

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

38

15

611

Delezé M

1988

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

39

15

80

Hazeltine M

1988

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

41

16

926

Delezé M, Alarcón-Segovia D

publication date

1989

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

The spectrum of livedo reticularis and anticardiolipin antibodies.

25 October 2022

42

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus

25 October 2022

44

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

46

15

890

Alarcón-Segovia D

1988

1 reference

https://api.crossref.org/works/10.3109/08916939108997126

25 October 2022

Identifiers

1 reference

26 July 2017

1 reference